Invesco Pharmaceuticals ETF Rating $77.35 +1.03 (+1.35%) As of 04/17/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy 2.69Holdings in PJP have an aggregate rating of Moderate Buy based on 387 analyst ratings issued in the past year covering 30 companies (99.8% of the portfolio).PJP Aggregate Price Target$77.35High Prediction$77.35Average Prediction$77.35Low Prediction$77.35Holdings in PJP have an aggregate price target of $77.35 and a range of $77.35 to $77.35 covering 30 companies (99.8% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 PJP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.34%ABTAbbott Laboratories$131.00+1.0%4.8638 of 5 stars2.84$142.59 8.8%19Earnings ReportEx-DividendAnalyst ForecastOptions VolumeAnalyst RevisionNews CoveragePositive News5.30%GILDGilead Sciences$104.49-0.4%4.529 of 5 stars2.72$105.12 0.6%29Upcoming EarningsInsider TradeNews CoveragePositive News5.22%JNJJohnson & Johnson$157.42+2.3%4.5043 of 5 stars2.56$171.82 9.1%18Earnings ReportDividend IncreaseAnalyst ForecastOptions VolumeAnalyst RevisionNews Coverage5.20%AMGNAmgen$277.29-1.9%4.6103 of 5 stars2.48$314.91 13.6%23Analyst DowngradeAnalyst RevisionNews CoveragePositive News4.97%ABBVAbbVie$172.78+0.6%4.8986 of 5 stars2.85$210.71 22.0%26Upcoming EarningsEx-DividendAnalyst ForecastAnalyst RevisionNews CoveragePositive News4.95%MRKMerck & Co., Inc.$77.93+1.9%4.9993 of 5 stars2.64$115.50 48.2%22Upcoming EarningsAnalyst ForecastPositive News4.71%PFEPfizer$22.13+0.4%4.9986 of 5 stars2.59$31.07 40.4%174.66%LLYEli Lilly and Company$841.70+14.5%4.7949 of 5 stars2.89$1,012.00 20.2%19News CoveragePositive NewsGap UpHigh Trading Volume3.80%ANIPANI Pharmaceuticals$69.21+0.0%3.6227 of 5 stars3.00$79.75 15.2%9Analyst UpgradeNews CoveragePositive News3.52%CORTCorcept Therapeutics$62.24-3.7%4.4072 of 5 stars3.00$143.25 130.2%5Positive News3.40%TARSTarsus Pharmaceuticals$49.25-0.3%2.8812 of 5 stars3.00$63.67 29.3%7News CoveragePositive News3.07%PRGOPerrigo$25.35+0.8%4.8522 of 5 stars2.25$33.00 30.2%4News CoveragePositive News3.02%INVAInnoviva$18.27+1.0%4.2514 of 5 stars3.00$55.00 201.0%2Positive News3.01%SUPNSupernus Pharmaceuticals$30.76+0.2%2.951 of 5 stars2.33$36.00 17.0%3Analyst UpgradeNews Coverage3.00%PCRXPacira BioSciences$24.65+0.7%2.12 of 5 stars2.33$26.67 8.2%92.94%PBHPrestige Consumer Healthcare$80.10+0.4%4.1678 of 5 stars2.50$93.33 16.5%6Positive News2.76%BMYBristol-Myers Squibb$49.24-0.3%4.729 of 5 stars2.32$57.67 17.1%19Upcoming EarningsShort Interest ↓Analyst RevisionNews CoveragePositive News2.72%COLLCollegium Pharmaceutical$27.010.0%4.096 of 5 stars2.80$43.60 61.4%5Analyst DowngradePositive News2.71%LGNDLigand Pharmaceuticals$104.97+0.3%4.3204 of 5 stars3.00$146.43 39.5%7Analyst UpgradeNews CoveragePositive News2.61%AMRXAmneal Pharmaceuticals$7.36+2.5%3.2201 of 5 stars3.00$10.80 46.7%5Short Interest ↑News CoveragePositive News2.55%LQDALiquidia$13.72+0.3%2.2577 of 5 stars3.11$26.63 94.1%9Insider TradeNews CoverageGap Up2.51%BIIBBiogen$118.61+2.9%4.6768 of 5 stars2.42$213.15 79.7%31Upcoming EarningsAnalyst ForecastAnalyst Revision2.49%HRMYHarmony Biosciences$28.46+1.9%4.5589 of 5 stars3.00$53.33 87.4%9Short Interest ↓Positive News2.48%UTHRUnited Therapeutics$284.73-0.2%4.921 of 5 stars2.67$388.25 36.4%12Analyst UpgradeInsider TradePositive News2.40%REGNRegeneron Pharmaceuticals$563.16+2.5%4.8399 of 5 stars2.77$963.56 71.1%26Analyst ForecastNews CoveragePositive News2.34%AMPHAmphastar Pharmaceuticals$23.35+1.6%4.2827 of 5 stars2.00$43.50 86.3%3News CoveragePositive News2.32%JAZZJazz Pharmaceuticals$102.78+1.2%4.8891 of 5 stars2.93$187.71 82.6%14News CoveragePositive News2.08%TVTXTravere Therapeutics$14.92+2.4%2.609 of 5 stars2.93$32.08 115.0%14Analyst RevisionPositive News2.01%VTRSViatris$7.56+2.3%2.8645 of 5 stars1.75$10.50 38.9%4News Coverage1.74%GERNGeron$1.27+2.4%3.7797 of 5 stars2.82$5.75 352.8%11Short Interest ↑ This page (NYSEARCA:PJP) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PJP Stock Free PJP Stock Alerts